摘要
Abstract
Objective Irbesartan and orka capsule at the same time apply to patients with chronic glomerulonephritis,the curative ef ect.Methods In the hospital treated 50 cases of patients with chronic glomerulonephritis were randomly divided into treatment group (irbesartan+orka capsule combination therapy)and control group (only applies irbesartan),both groups after 2 months of treatment, quantitative measurement,serum creatinine(SCr),content urobilin(BUN)and other indicators of urinary protein determination by comparing the two treatment indicators.Results The inspection results of the treatment group than the control group,especial y urinary protein quantitative reduction is very obvious,and <0.05.Conclusion Irbesartan+orka capsule for application in patients with chronic glomerulonephritis treatment can significantly control the content of proteinuria in patients,to improve the poor condition of the patient,it is worth in the treatment of these diseases widely used.关键词
厄贝沙坦/黄葵胶囊/慢性肾小球肾炎/蛋白尿Key words
Irbesartan/Orka capsule/Chronic glomerulonephritis/Proteinuria
